SYNTHESIS AND EVALUATION OF SOME NOVEL 5-ARYLIDENE-2-(7-CHLOROQUINOLIN-6-YL)-3-(PYRIMIDIN-2-YL) THIAZOLIDIN-4-ONES AS ANTI-MICROBIAL AGENT

The pyrimidine moiety is a crucial heterocyclic compound widely present in the human body, exhibiting diverse biological activities such as antimicrobial, anti-inflammatory, anti-coagulant, antihypertensive, and antitubercular properties. It is integral to nucleic acids and enzymes in living organisms, offering potential as both antagonist and agonist drugs.

The rise of resistance to antibiotics and other antimicrobial agents poses a significant global challenge today. As microbes develop resistance to current treatments, the battle between bacteria and humans intensifies, often resulting in adverse outcomes for human health. Addressing these challenges requires controlling the overuse of antibiotics, which exacerbates resistance, and developing novel antibiotics with enhanced potency and efficacy.

To mitigate these challenges and improve treatment outcomes, discovering new antimicrobial agents with improved safety profiles remains paramount. This study focuses on the synthesis and evaluation of novel pyrimidine derivatives as potential antimicrobial agents, aiming to contribute to the ongoing efforts against microbial resistance.

In this study, we synthesized and assessed the antimicrobial activity of novel 5-arylidene-2-(7-chloroquinolin-6-yl)-3-(pyrimidin-2-yl) thiazolidin-4-ones. All the synthesized derivatives were meticulously characterized and their structures confirmed through spectroscopic analysis. These compounds exhibited significant activity against both bacterial and fungal agents, highlighting their potential as effective antimicrobial agents. As we continue to face evolving challenges in microbial resistance, these findings underscore the importance of exploring novel therapeutic strategies to safeguard public health.